Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

Most likely, the costs of NEO are too high based on preliminary data. Recall they had mfg issues before starting the 1st dosing. It looks like these issues were not resolved completely.
Phase 1 is not to evaluate efficacy of the drug, thus I do not believe the efficacy or the lack of thereof was the reason for the termination.
The company must have been blindsided by this decision to terminate, thus, no CC at this point. They say in 8-K they would re-evaluate whether to re-partner or not. It would be very hard to, and instead they need to focus on HOT if they stand any chance to survive.

Survival of the company is at the stake now. Ken needs to step up and do some explaining here. Tomorrow should be a good time to do so.